AnaptysBio Investigative Site 10-122 — Atlanta, Georgia

AnaptysBio Investigative Site 10-122 is a clinical research site located in Atlanta, Georgia, United States 30328.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

AnaptysBio Investigative Site 10-122 has participated in 1 clinical trials.

Therapeutic areas: Atopic Dermatitis Eczema.

Sponsors: AnaptysBio, Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for AnaptysBio Investigative Site 10-122?

AnaptysBio Investigative Site 10-122 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has AnaptysBio Investigative Site 10-122 conducted?

AnaptysBio Investigative Site 10-122 has 1 clinical trials on record. Their work covers Atopic Dermatitis Eczema.

Is AnaptysBio Investigative Site 10-122 accredited by Crixeo Health?

AnaptysBio Investigative Site 10-122 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about AnaptysBio Investigative Site 10-122?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.